Fractyl Health, Inc.
GUTS
Rank in Stocks
#28228
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for... Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Share Price
$0.8971
Last synced: 2026-11-09
Market Cap
$11.90M
Change (1 day)
-3.52%
Change (1 year)
-18.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fractyl Health, Inc. (GUTS)
Category
Healthcare
EPS for Fractyl Health, Inc. (GUTS)
EPS as of June 2026 TTM: $-13.20
According to Fractyl Health, Inc.'s latest financial reports, its current EPS (TTM) is $-13.20. At the end of 2025 the company had an EPS of $-11.04, an increase over its 2024 EPS of $-19.44.
EPS history for Fractyl Health, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-13.20 | 19.57% |
| 2025 | $-11.04 | -43.21% |
| 2024 | $-19.44 | -18.18% |
| 2023 | $-23.76 | 47.76% |
| 2022 | $-16.08 | 19.64% |
| 2021 | $-13.44 | 30.23% |
| 2020 | $-10.32 | 34.38% |
| 2019 | $-7.68 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -218.64% |
US
|
|
| $-7.07 | -46.44% |
US
|
|
| $-5.29 | -59.92% |
AU
|
|
| $12.88 | -197.58% |
BE
|
|
| $21.56 | -263.33% |
NL
|
Questions about Fractyl Health, Inc.'s earnings per share (EPS)
What is Fractyl Health, Inc.'s earnings per share (EPS)?
Fractyl Health, Inc.'s earnings per share (EPS) over the last twelve months is $-13.20, as of Jun 2026.
What was Fractyl Health, Inc.'s earnings per share (EPS) in 2025?
In 2025, Fractyl Health, Inc.'s earnings per share (EPS) was $-11.04, compared with $-19.44 in 2024.
How has Fractyl Health, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fractyl Health, Inc.'s earnings per share (EPS) was highest in 2020 ($-10.32) and lowest in 2023 ($-23.76).
How does Fractyl Health, Inc.'s earnings per share (EPS) compare with similar companies?
Fractyl Health, Inc.'s earnings per share (EPS) ($-13.20) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.